Verity Asset Management’s Madrigal Pharmaceuticals MDGL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$609K	Buy	1,164 +6	+0.5%	+$2.87K	0.26%	110
2025 Q4	$674K	Sell	1,158 -102	-8%	-$52.1K	0.29%	95
2025 Q3	$578K	Sell	1,260 -457	-27%	-$170K	0.19%	120
2025 Q2	$520K	Buy	1,717 +157	+10%	+$46.8K	0.25%	100
2025 Q1	$517K	Buy	1,560 +70	+5%	+$23K	0.21%	110
2024 Q4	$460K	Buy	1,490 +24	+2%	+$6.75K	0.26%	90
2024 Q3	$311K	Buy	1,466 +101	+7%	+$25.8K	0.12%	154
2024 Q2	$382K	Sell	1,365 -209	-13%	-$49.8K	0.15%	125
2024 Q1	$420K	Sell	1,574 -1,115	-41%	-$263K	0.23%	113
2023 Q4	$622K	Buy	2,689 +2	+0.1%	+$350	0.4%	64
2023 Q3	$392K	Buy	2,687 +721	+37%	+$136K	0.29%	92
2023 Q2	$454K	Buy	1,966 +492	+33%	+$133K	0.34%	82
2023 Q1	$357K	Buy	1,474 +452	+44%	+$123K	0.21%	109
2022 Q4	$297K	Sell	1,022 -2,830	-73%	-$277K	0.25%	118
2022 Q3	$250K	Buy	+3,852	New	+$268K	0.26%	125
2022 Q1	$275K	Buy	2,801 +145	+5%	+$12.2K	0.17%	157
2021 Q4	$225K	Sell	2,656 -320	-11%	-$26.3K	0.13%	178
2021 Q3	$237K	Buy	2,976 +618	+26%	+$53.4K	0.15%	159
2021 Q2	$230K	Buy	2,358 +49	+2%	+$5.8K	0.13%	198
2021 Q1	$270K	Buy	2,309 +464	+25%	+$54.1K	0.16%	166
2020 Q4	$205K	Buy	+1,845	New	+$226K	0.14%	151
2015 Q4	–	Sell	-1,842	Closed	-$112K	–	90
2015 Q3	$112K	Sell	1,842 -492	-21%	-$35.5K	0.11%	88
2015 Q2	$182K	Buy	2,334 +719	+45%	+$60.3K	0.16%	85
2015 Q1	$110K	Sell	1,615 -739	-31%	-$63.4K	0.11%	78
2014 Q4	$218K	Sell	2,354 -63	-3%	-$6.51K	0.21%	68
2014 Q3	$254K	Sell	2,417 -412	-15%	-$57.3K	0.29%	52
2014 Q2	$405K	Sell	2,829 -114	-4%	-$16.7K	0.44%	44
2014 Q1	$456K	Buy	2,943 +218	+8%	+$42.9K	0.47%	35
2013 Q4	$500K	Buy	+2,725	New	+$499K	0.55%	23